HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (NYSE:TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2015.
Quarter ended March 31, 2015 Highlights - compared to March 31, 2014
•Net sales of $244.2 million, increased $57.0 million, or 30.5%, on flat volumes
Help employers find you! Check out all the jobs and post your resume.
Quarter ended March 31, 2015 Highlights - compared to March 31, 2014
•Net sales of $244.2 million, increased $57.0 million, or 30.5%, on flat volumes
Help employers find you! Check out all the jobs and post your resume.
